• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

角质形成细胞在良性和恶性皮肤疾病中表达二肽基肽酶IV(CD26)。

Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases.

作者信息

Novelli M, Savoia P, Fierro M T, Verrone A, Quaglino P, Bernengo M G

机构信息

Clinica Dermatologica I dell'Università di Torino, Italy.

出版信息

Br J Dermatol. 1996 Jun;134(6):1052-6.

PMID:8763423
Abstract

CD26 expression on keratinocytes, in both normal and pathological skin, was investigated using immunohistochemical techniques. A sporadic focal CD26 positivity was found in normal skin, whereas increased expression of CD26 was observed both in cutaneous T-cell lymphomas and in inflammatory skin diseases, e.g. psoriasis, lichen planus and spongiotic dermatitis, in the basal and spinous layers. CD26 keratinocyte staining was not specific for a single disease, but seems to be associated with the presence of a reactive or neoplastic infiltrate in the epidermis. We propose that the CD26 molecule may function as a keratinocyte activation antigen.

摘要

运用免疫组化技术研究了正常和病理皮肤中角质形成细胞上CD26的表达情况。在正常皮肤中发现散在局灶性CD26阳性,而在皮肤T细胞淋巴瘤以及炎症性皮肤病如银屑病、扁平苔藓和海绵状皮炎的基底和棘层中观察到CD26表达增加。CD26角质形成细胞染色并非某一种疾病所特有,而是似乎与表皮中反应性或肿瘤性浸润的存在相关。我们提出CD26分子可能作为一种角质形成细胞活化抗原发挥作用。

相似文献

1
Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases.角质形成细胞在良性和恶性皮肤疾病中表达二肽基肽酶IV(CD26)。
Br J Dermatol. 1996 Jun;134(6):1052-6.
2
Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.皮肤淋巴细胞抗原在良性和肿瘤性皮肤B细胞及T细胞淋巴浸润中的表达
J Cutan Pathol. 2008 Nov;35(11):1040-9. doi: 10.1111/j.1600-0560.2007.00971.x. Epub 2008 Aug 4.
3
Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).Toll样受体2、4和9在皮肤T细胞淋巴瘤(蕈样肉芽肿和Sezary综合征)中的表达
Eur J Dermatol. 2006 Nov-Dec;16(6):636-41.
4
Interleukin-7 receptor expression in cutaneous T-cell lymphomas.白细胞介素-7受体在皮肤T细胞淋巴瘤中的表达
Br J Dermatol. 1996 Oct;135(4):572-5.
5
Expression of epithelial antigens Exo-1 and EPM-1 in human epidermal keratinocyte maturation and benign and malignant neoplasia.上皮抗原Exo-1和EPM-1在人表皮角质形成细胞成熟以及良性和恶性肿瘤中的表达
Cancer Res. 1990 Dec 1;50(23):7668-76.
6
Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.CD30阴性原发性皮肤大T细胞淋巴瘤中辅助性T细胞2细胞因子信使核糖核酸表达缺失
Arch Dermatol. 2001 Jul;137(7):901-5.
7
CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.银屑病皮肤中的CD26/二肽基肽酶IV:上调及拓扑学变化
Br J Dermatol. 2008 Jun;158(6):1264-72. doi: 10.1111/j.1365-2133.2008.08515.x. Epub 2008 Mar 29.
8
T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.采用多重聚合酶链反应/异源双链分析检测皮肤T细胞淋巴瘤(蕈样肉芽肿/ Sézary综合征)和良性炎症性疾病患者的T细胞受体γ基因重排:与临床、组织学和免疫表型结果的相关性
Br J Dermatol. 2005 Sep;153(3):565-73. doi: 10.1111/j.1365-2133.2005.06649.x.
9
Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome.外周血中皮肤归巢CLA+ CD4+ T淋巴细胞上CD26表达缺失是蕈样肉芽肿患者早期诊断和治疗监测的高度敏感标志物。
Clin Exp Dermatol. 2005 Nov;30(6):702-6. doi: 10.1111/j.1365-2230.2005.01904.x.
10
[Skin associated lympphoid tisues (SALT). Its normal and pathological function].[皮肤相关淋巴组织(SALT)。其正常及病理功能]
An R Acad Nac Med (Madr). 2006;123(2):367-77; discussion 377-9.

引用本文的文献

1
Psoriasis Risk Is Lower in Type 2 Diabetes Patients Using Dipeptidyl Peptidase-4 Inhibitors or Thiazolidinediones Compared to Sulfonylureas.与使用磺脲类药物相比,2型糖尿病患者使用二肽基肽酶-4抑制剂或噻唑烷二酮类药物时患银屑病的风险更低。
Clin Transl Sci. 2025 Mar;18(3):e70177. doi: 10.1111/cts.70177.
2
HDAC1/2 Control Proliferation and Survival in Adult Epidermis and Pre‒Basal Cell Carcinoma through p16 and p53.HDAC1/2 通过 p16 和 p53 控制成年表皮和基底细胞癌前细胞的增殖和存活。
J Invest Dermatol. 2022 Jan;142(1):77-87.e10. doi: 10.1016/j.jid.2021.05.026. Epub 2021 Jul 18.
3
Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease? A population-based study.
二肽基肽酶-4 抑制剂与自身免疫性疾病之间是否存在关联?一项基于人群的研究。
Immunol Res. 2018 Jun;66(3):425-430. doi: 10.1007/s12026-018-9005-8.
4
Dipeptidyl peptidase-4 inhibition and narrow-band ultraviolet-B light in psoriasis (DINUP): study protocol for a randomised controlled trial.二肽基肽酶-4抑制剂与窄谱中波紫外线光治疗银屑病(DINUP):一项随机对照试验的研究方案
Trials. 2016 Jan 15;17:29. doi: 10.1186/s13063-016-1157-z.
5
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study.2型糖尿病患者使用二肽基肽酶-4抑制剂可能降低自身免疫性疾病风险:一项基于人群的队列研究
Ann Rheum Dis. 2015 Nov;74(11):1968-75. doi: 10.1136/annrheumdis-2014-205216. Epub 2014 Jun 11.
6
Differential expression of dipeptidyl peptidase IV in human versus cynomolgus monkey skin eccrine sweat glands.人源与食蟹猴皮肤外分泌汗腺中二肽基肽酶 IV 的差异表达。
J Mol Histol. 2013 Dec;44(6):733-47. doi: 10.1007/s10735-013-9524-5. Epub 2013 Jul 24.
7
CD26 expression on CD4+T cells in patients with cutaneous leishmaniasis.皮肤利什曼病患者CD4+T细胞上CD26的表达
Clin Exp Immunol. 2008 Jul;153(1):31-6. doi: 10.1111/j.1365-2249.2008.03666.x. Epub 2008 May 5.
8
Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy.对5个基因进行定量PCR可可靠地识别循环肿瘤细胞比例为5%至99%的蕈样肉芽肿患者,准确率达90%。
Blood. 2006 Apr 15;107(8):3189-96. doi: 10.1182/blood-2005-07-2813. Epub 2006 Jan 10.